Asish is based in the Johnson & Johnson California Innovation Center in Menlo Park, CA.  Asish focuses on venture investments in biotechnology and diagnostics.  Asish joined JJDC in 2004, and has invested in over 20 biotechnology and diagnostics deals.

Asish previously worked in business development at BioRexis Pharmaceutical Corporation (King of Prussia, PA) which was acquired by Pfizer in 2007.  While at BioRexis, he assisted the company in raising a $30 million round of financing.  Asish has worked in business development at Structural GenomiX, Inc. (San Diego, CA), acquired by Eli Lilly in 2008; and, was a project leader at Message Pharmaceuticals, Inc. (Malvern, PA).

Asish received a Ph.D. in Chemical Engineering from the University of Houston and a MBA from the Wharton School of the University of Pennsylvania, where he graduated with honors.  He received a Bachelor of Technology in Chemical Engineering from the Indian Institute of Technology, Kanpur, India.  Asish was a postdoctoral research fellow in the Department of Chemistry at the Johns Hopkins University.